Evidence map›Paper›PMID 30626605›Full record

ArticleCancer discovery2019

Circulating Tumor Cells: Come Together, Right Now, Over Metastasis.

Paulo Rodrigues, Sakari Vanharanta

Registry-linked trialAbstract readComment
In one paragraph

Article in Cancer discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06416436 (Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06416436 phase1withdrawnnot on this mapstarted 2024, after this paper: background citation

Immunotherapy in Combination With Ablative Radiosurgery to Ultra-high DoSes (ICARUS): A Phase I Dose-escalation Radiosurgery Study in Metastatic Cancers

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2024 to 2024Enrolled0ConditionsSolid TumorArmsAtezolizumab, Stereotactic Ablative Radiotherapy (SBRT)
3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Paulo RodriguesMedical Research Council (MRC) Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK.
Sakari VanharantaMedical Research Council (MRC) Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK. sv358@mrc-cu.cam.ac.uk.

Funding

Medical Research Council MC_UP_1101/4Medical Research Council MC_UU_12022/7Medical Research Council MR/N501876/1
6 · The paper itself

Abstract

Circulating tumor cells (CTC) are the source of metastases, but only an infinitesimal fraction of them eventually succeed in colonizing a distant organ. New results show that CD44-dependent aggregation in the circulation provides CTCs with cancer stem cell-like characteristics, suggesting an explanation for the low metastatic efficiency of CTCs, but also avenues for therapeutic intervention.

Indexed as

Breast NeoplasmsNeoplastic Cells, CirculatingCell AggregationHumansHyaluronan ReceptorsNeoplastic Stem CellsCD44 protein, humanHyaluronan Receptors

Identifiers

PMID30626605
PMCPMC6420083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.